When healthcare providers fail to share essential information either with patients or with other members of the care team, the results can be catastrophic.
The increased use of compounded medications—particularly driven by the glucagon-like peptide-1 (GLP-1) therapies and ketamine assisted psychotherapy—has drawn renewed attention to their role in modern treatment.
Have you ever wondered what happens if an on-call specialist says no? What if they refuse to accept a transfer, decide not to treat a patient, or perform a procedure?